Patent · US Expired

Benzimidazoles and pharmaceutical compositions containing them

US5565469A · kind A · utility

24Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 1995
Grant dateOct 15, 1996
Priority date
Expiry dateMar 13, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Angiotensin-II inhibiting benzimidazoles, useful for the treatment of hypertension. Exemplary compounds are: PA0 (a) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(1,3-thiazolidin-2,4-dione-5-methylidinyl)-biphenyl, PA0 (b) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-sulpho-biphenyl, PA0 (c) 4'-[(2-ethyl-4-methyl-6-(5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl)-be nzimidazol-1-yl)-methyl]-2-sulpho-biphenyl, PA0 (d) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-trifluoroacetylamino-biphenyl, PA0 (e) 4'-[(2-ethyl-4-methyl-6-(5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl)-be nzimidazol-1-yl)-methyl]-2-trifluoroacetylamino-biphenyl, PA0 (f) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(4-methoxy-benzylaminocarbonylaminosulphonyl)-biphenyl, PA0 (g) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(cyclohexylamino-carbonylaminosulphonyl)-biphenyl, PA0 (h) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(benzoylamino-sulphonyl)-biphenyl, PA0 (i) 4'-[(2-ethyl-4…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.